Womens Health
Mfg : StriveBremelanotide Mini Troche
Hormone-Free Approach: Works through the brain’s natural desire pathways, not hormonal shifts.
Clinically Recognized Ingredient: Contains the same active component found in FDA-approved Vyleesi®.
Quick Sublingual Troche: Designed to dissolve under the tongue with effects in 90–120 minutes.
Whole-Experience Enhancement: Helps improve desire, arousal, and intimate satisfaction.
Private and Simple Use: No injections needed—just a discreet, convenient option.
Disclaimer: The FDA may not have evaluated this product for safety, effectiveness, or quality.Maximum Doses: 4
Per Dose $ 00.00
Total Price
Bremelanotide (PT-141) offers a unique approach compared to traditional libido treatments. It is not a hormone and does not interfere with estrogen or testosterone levels. Instead, it works as a melanocortin receptor activator that influences the central nervous system. By stimulating specific receptors in the hypothalamus, it helps engage the body’s natural desire and arousal response, supporting sexual wellness through neurological pathways rather than hormonal alteration.
This therapy is intended for women experiencing Hypoactive Sexual Desire Disorder (HSDD), a persistent lack of sexual interest that can cause emotional distress. Research suggests PT-141 may help: increase sexual desire, promote more frequent arousal, enhance satisfaction, and reduce frustration associated with low libido. It focuses on the mental and neurological drivers of desire, which are often central to female sexual response.
Our mini troche is formulated to dissolve under the tongue, allowing absorption directly into the bloodstream. This delivery method: provides a quicker onset of action (often within 90–120 minutes), avoids breakdown in the digestive tract, improves overall absorption, and offers a discreet, needle-free alternative. The smooth mint taste makes it easy to use comfortably.
Because PT-141 does not involve hormone manipulation, it avoids many concerns associated with hormonal therapies. Side effects are usually mild and may include temporary nausea, flushing, or headache. It should not be used during pregnancy or breastfeeding, or by individuals with uncontrolled high blood pressure. Effects are short-term and dose-dependent, allowing for individualized control and predictability.
For optimal results, place one troche beneath the tongue and allow it to fully dissolve about 1–2 hours before intimacy. Benefits may last several hours, supporting both planning and spontaneity. Many patients begin with less frequent use to understand their personal response. This option works best when paired with emotional comfort, communication, and a supportive intimate setting.
